Literature DB >> 16355118

Awareness of the Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2000) and compliance to its recommendations: surveys in 2000 and 2004.

N Ikeda1, T Hasegawa, T Hasegawa, I Saito, T Saruta.   

Abstract

Clinic physicians' awareness of the Japanese hypertension guideline (JSH 2000) and compliance with its recommendations were assessed to derive policy implications for effective blood pressure control. Data were obtained from two postal questionnaire surveys conducted in 2000 and 2004, and subjects were 896 and 1425 clinic physicians, respectively, who were engaged in general internal medicine. Recognition rates of JSH 2000 were 63.1% (n = 822) before its announcement in 2000 and 94.4% (n = 1400) in 2004. Rates of access, familiarity and utilisation of JSH 2000 were 87.0, 81.6 and 68.9%, respectively (n = 1400) in 2004. As for major management strategies for low-risk hypertension: in 2000, for patients with 140-149/90-94 mmHg, 81.5% of 812 respondents performed lifestyle modification, and 11.2% prescribed medicines, whereas for patients with 150-159/95-99 mmHg, 71.7% of 807 respondents prescribed medicines, and 24.3% conducted lifestyle modification; in 2004, 90.0% of 1384 respondents conducted lifestyle modification, 22.6% prescribed medicines, 2.5% referred patients to other facilities, and 6.4% did nothing. In 2004, 68.9% of 1388 respondents agreed with the new definition of hypertension, whereas 17.1% preferred 160/95 mmHg. Respondents' age (P<0.05) and a percentage of hypertensives in daily patient load (P<0.0005) significantly associated with the choice of the old criteria. In conclusion, JSH 2000 achieved a substantial improvement in clinic physicians' awareness and their compliance to its recommendations on low-risk hypertension management. One of the strategies for further enhancement in their compliance with JSH 2004 would be its dissemination to those who are old and/or do not see hypertensive patients so frequently.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16355118     DOI: 10.1038/sj.jhh.1001977

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  5 in total

1.  Awareness of the Japanese Society of Hypertension Guidelines for the Management of Hypertension and their use in clinical practices: 2009 survey results.

Authors:  Taku Obara; Sergio Ramón Gutiérrez Ubeda; Takayoshi Ohkubo; Hideo Matsuura; Toshihiko Ishimitsu; Masanobu Takata; Hiromi Rakugi; Yutaka Imai
Journal:  Hypertens Res       Date:  2015-04-02       Impact factor: 3.872

2.  Efficacy and Tolerability of Nilvadipine in Combination with an Angiotensin II Receptor Antagonist in Patients with Essential Hypertension: A Multicenter, Open-Label, Uncontrolled Study.

Authors:  Keita Noda; Munehito Ideishi; Eiichiro Tashiro; Yoshiyuki Nakashima; Mitsuhide Imamura; Masahiko Seki; Masanori Fujino; Toshimitsu Sou; Masaki Kohara; Hisashi Kanaya; Nishiki Saku; Ritsu Kamei; Misao Yamasaki; Hiroshi Sakai; Naoki Gondo; Keijiro Saku
Journal:  Curr Ther Res Clin Exp       Date:  2003-03

3.  Relationship of Annual Health Checkups with the Subject's Subsequent Behavior of Cardiovascular Risk Management in a Real-World Setting in Japan: A Retrospective Cohort Study on Changes in Antihypertensive Drug Prescription and Blood Pressure from 2015 to 2017.

Authors:  Shingo Higa; Yoichi Ii; Kazutaka Nozawa; Yuji Yamamoto; Kazuhiro Ohwaki; Yuko Asami
Journal:  Drugs Real World Outcomes       Date:  2021-01-15

4.  Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys.

Authors: 
Journal:  Lancet       Date:  2019-07-18       Impact factor: 79.321

5.  Doctors' Knowledge of Hypertension Guidelines Recommendations Reflected in Their Practice.

Authors:  Nafees Ahmad; Amer Hayat Khan; Irfanullah Khan; Amjad Khan; Muhammad Atif
Journal:  Int J Hypertens       Date:  2018-03-12       Impact factor: 2.420

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.